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3 Abstract 
 
The purpose for this PhD research is to find a novel gene induced by neurite outgrowth on 
amphoterin substrate. The finding was a gene that codes type-I transmembrane protein 
with six leucine-rich repeat (LRR) motifs and one immunoglobulin domain followed by a 
short cytoplasmic tail. We named this gene as amphoterin-induced gene and ORF 
(Amigo).  
 
Further characterization of AMIGO protein revealed that AMIGO itself is a neurite 
outgrowth promoting factor and it is also required for the fasciculation of neurites both in 
vitro and in vivo. The mode of these functions was shown to be homophilic, which puts 
AMIGO in a group of homophilic cell adhesion molecules. We crystallized the 
extracellular domain of AMIGO to elucidate the mechanism for its functions. AMIGO 
crystallized as a homophilic dimer where the concave face of the LRR domain was the 
interface for dimerization. The isolation of Amigo allowed us to characterize two other 
homologous genes called Amigo2 and Amigo3 and together they form the novel Amigo 
gene family. 
 
AMIGO protein was found to be an auxiliary subunit of the voltage-gated potassium 
channel Kv2.1 in adult animals. AMIGO mediates the regulation of the voltage-gating 
properties of Kv2.1. This AMIGO/Kv2.1 interaction was also studied at the whole animal 
level by using Amigo knockout mice whereby the lack of Amigo changed voltage-gated 
potassium currents and resulted in behavioral problems related to human schizophrenia. 
 
All these findings suggest that AMIGO has two separate roles in the central nervous 
system (CNS). First, AMIGO is a homophilic adhesion molecule that supports neurite 
outgrowth and fasciculation of the neurites during development. Second, the AMIGO 
regulates the properties of the voltage-gated potassium channel Kv2.1 in the mature CNS. 
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4 Introduction 
 
The human brain is thought to be the most complex structure in the known universe. Our 
brain contains 100 billion neurons and every neuron is interconnected to another via 
numerous axons and dendrites, collectively known as neurites. The whole human brain 
contains 100 trillion synapses. Our knowledge of this intriguing organ has evolved from a 
mucus producing function (Egyptians) to a blood cooling organ (Aristotle) to a ventricle 
driven machine (Galen), and finally to the neuron doctrine (Cajal, Waldeyer-Hartz etc.) 
for which neurons are central to the brain functions. 
Neurons are very peculiar cells compared to other cell types seen in 
multicellular organisms. During development, the nervous system neurons send axons that 
make contact with other neurons or non-neuronal cells much further than the close vicinity 
of the cell´s own environment. This process is called neurite outgrowth whereby trophic 
factors, the extracellular matrix and cell surface adhesion molecules guide neurites to find 
their right targets. The longest neurites in the contemporary animal kingdom are whale 
dorsal root ganglion neurites which can be over 20 meters long. How can neurons send 
signals so far from the cell soma? Diffusion inside or on the membrane surface would be 
far too slow and even active transport with the aid of motor proteins is just not fast 
enough. Evolution has solved this problem by producing neurons with another specialized 
characteristic called electrochemical communication. In electrochemical communication 
information moves fast enough in active organisms which allows them to act efficiently 
and cope in changing environments and have perceptions that closely enough match 
reality. 
 
4.1 Neurite outgrowth 
In the early 1950s, Levi-Montalcini together with Cohen (Cohen et al., 1954) pioneered 
the field of developmental neuroscience when they found the first polypeptide with neurite 
outgrowth promoting properties which they called nerve growth factor (NGF). This 
finding opened a new field in neuroscience, and search of novel neurite promoting factors 
still continues. Neurite outgrowth is a phenomenon in which neurons extend cytoplasmic 
processes that later polarize into either axons or dendrites. The outgrowth of these neurites 
is important for the establishment of synaptic connections, which finally leads to brain 
functions (da Silva and Dotti, 2002). In this introduction, I will discuss major regulatory 
molecules of neurite outgrowth, with special emphasis upon neuronal leucine-rich repeat 
(LRR) proteins. 
 
4.1.1 Neurotrophins 
Many neurite outgrowth promoting factors have a dual nature because they have both 
neurite outgrowth and cell survival promoting functions. This is also true in the case of 
NGF which belongs to the group of molecules called neurotrophins. A common feature of 
these molecules is that they all share signaling receptors, which belong to two distinct 
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classes: P75(NTR) and Trk receptor family (Reichardt, 2006).  These important molecules 
have been studied widely over recent decades and many of these molecules or other 
molecules that are linked to their functions are being adopted by clinics to help to treat 
various diseases of the central nervous system (CNS) (Schulte-Herbruggen et al., 2007).  
 
4.1.2 Extracellular matrix 
The extracellular matrix (ECM) concept is defined in this review to mean only the specific 
ECM found in the CNS, which is the structure outside the cells that gives both support and 
guidance for neurons. This matrix is mainly composed of hyaluronic acid, chondroitin 
sulfate proteoglycans of the lectican family, and tenascin-R. These large molecules 
combine and form heterogeneous ternary complexes which are then decorated with 
various other molecules (Wang and Fawcett, 2012). Knowledge of the ECM components 
in the perineuronal nets and how these molecules modulate neuronal functions is only just 
beginning to emerge. 
 
4.1.2.1 Proteoglycans  
Chondroitin sulfate chains (CSCs) that attach to the protein core of aggrecan and neurocan 
are important components of the neuronal ECM (Yamaguchi, 2000). It was believed for a 
long time that the CSCs have a rather homogenous composition but recent accumulating 
evidence suggest that the CSCs have different compositions during the CNS development 
(Maeda et al., 2011). This dynamic change in composition might explain why during early 
CNS development the CSCs have neurite outgrowth promoting functions but later in the 
adult animal the CSCs can be the main barrier to axonal growth in the form of the glial 
scar (Silver and Miller, 2004). The other highly and developmentally expressed 
proteoglycans in the CNS are proteins that contain heparan sulfate chains (HSCs), which 
bind many growth factors and morphogens. This function was efficiently shown in a study 
in which the HSC synthesis was conditionally disrupted in the developing mouse CNS and 
which resulted in malformations and neurite outgrowth defects (Inatani et al., 2003). The 
HSC mode of function in the developing brain is to enrich and present the neurite 
outgrowth promoting molecules in their correct places thus forming concentration 
gradients for the growth cones to follow (Yamaguchi et al., 2010). 
 
4.1.2.2 Laminin 
Laminins are major components of the basal lamina, which is the protein layer that 
supports most cells and organs. Manthorpe et al. (1983) made the original finding that the 
laminin coated coverslips promote robust neurite outgrowth of chicken and rat neurons in 
vitro. Later on, the integrin receptor family was shown to be involved in the binding of 
laminin and the promotion of neurite outgrowth (Ignatius and Reichardt, 1988).  
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4.1.2.3 HMGB1 (Amphoterin) 
HMGB1 was isolated as the heparin binding p30 protein, which promoted neurite 
outgrowth of the rat CNS neurons (Rauvala and Pihlaskari, 1987). Later on the DNA and 
protein sequence of p30 were discovered and the protein renamed amphoterin (Merenmies 
et al., 1991) and it was also discovered that the same protein was identified as the nuclear 
protein called HMG1 (Paonessa et al., 1987). Finally the protein nomenclature was again 
revised and the protein was called HMGB1 (Bustin, 2001). Even though the first findings 
were that HMGB1 localization is both extracellular and intracellular, it was first studied 
more as a nuclear protein specifically a nonhistone architectural chromosomal protein. 
HMGB1 binds double stranded DNA non-specifically but together with other DNA 
binding proteins it facilitates nuclear hormone receptors to activate gene expression 
(Bianchi and Beltrame, 2000). An important finding for extracellular functions for 
HMGB1 was the discovery of the cell surface receptor for HMGB1 called RAGE (Hori et 
al., 1995), which has been shown to have a significant role in the neurite outgrowth 
promoting functions of  HMGB1 (Huttunen et al., 1999; Huttunen et al., 2002). 
Nowadays, the focus of HMGB1/RAGE studies is mostly on inflammatory axis where 
both molecules have been shown to have important functions in the immune system (Sims 
et al., 2010). 
  
4.1.3 Cell adhesion molecules 
Cell adhesion molecules (CAMs) are cell surface transmembrane proteins that attach the 
cells to ECM or to other cells. They serve as mechanical links for the cell but they also 
pass signals into the cell about the surroundings in which it is located. The CAMs are 
commonly divided in four distinctive families; integrins, cadherins, selectins and 
immunoglobulin superfamily (IgSF) of which integrins, cadherins and IgSF molecules are 
important for neurite outgrowth and CNS development. The modus operandi for the 
CAMs can be heterophilic whereby the CAMs bind to ECM molecules or to different cell 
surface proteins located on other cells. The modus operandi of the CAMs can also be 
homophilic, which entails the CAMs binding to the same molecules located on other cells. 
A common feature for the CAMs is a short cytoplasmic domain, and signaling of the 
CAMs depends on the interaction with other cytoplasmic signaling molecules/complexes. 
The outcome of the CAM signaling is often a remodeling of the actin cytoskeleton and a 
shaping of the cell morphology (Aplin et al., 1999).  
4.1.3.1 Integrins 
Intergrins form a major CAM family which has 24 receptors for different ligands. 
Integrins that target laminin or RGD motif containing proteins such as fibronectin are 
evolutionary ancient and can be found throughout all metazoan. In contrast integrins that 
target collagens and leukocytes are only found in vertebrates (Hynes, 2002). Integrin 
signaling is in most cases associated with the actin cytoskeleton through talin protein, 
which is involved in the unique “inside to out” integrin signaling in addition to the 
canonical “outside to in” signaling for receptors (Das et al., 2014). Integrins are mostly 
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expressed during the CNS development and the expression is more modest in the adult 
brain but recent findings suggest that the integrins could be very potent targets in 
therapeutic use for CNS injuries because of their very potent neurite outgrowth promoting 
properties (Eva et al., 2012). 
 
4.1.3.2 Cadherins 
Cadherins constitute a large superfamily of transmembrane proteins, and in humans more 
than 80 members have been found. In the neurite outgrowth function and the CNS 
development the most important member of the family is called N-cadherin, which 
belongs to the classical cadherin subfamily. Classical cadherins (referred to as cadherins 
here) are calcium ion dependent cell-to-cell adhesion molecules, which make homophilic 
contacts from opposing cells (Tepass et al., 2000). Cadherins have short conserved 
cytoplasmic tails that interact with beta-catenin, which leads to signaling through the 
catenin complex to the actin cytoskeleton (Ratheesh and Yap, 2012). N-cadherin is 
important for mouse embryonic development because homozygous knockout embryos die 
by day 10 of gestation (Radice et al., 1997), and later on it was shown that N-cadherin is 
crucial for mouse brain development (Luo et al., 2001). It is thought that N-cadherin 
together with other cadherins are important guiding molecules for neurite outgrowth and 
for fasciculation of neurites to bundles and for making anatomically defined areas in the 
developing and adult CNS (Redies, 2000).   
 
4.1.3.3 Ig-superfamily 
The immunoglobulin (Ig) domain is the most frequently used protein domain in 
vertebrates. The Ig domain is a characteristic sandwich like structure with two antiparallel 
beta-sheets joined together by a conserved cysteine bridge. This resulting structure forms a 
versatile domain that can be adapted to bind to other Ig domain containing proteins such 
as cell receptors, adhesion molecules or a variety of other molecules such as antigens and 
sugars. In cell adhesion IgSF molecules form homophilic and heterophilic interactions 
with other IgSF molecules but they can also bind to other protein domains in different 
CAMs and in the ECM (Barclay, 2003). The IgSF molecules are the most actively used 
entity in cell-cell adhesion, neuronal migration, axonal guidance and synapse formation in 
the nervous system. 
 
4.1.3.3.1 NCAM 
Neural cell adhesion molecule (NCAM) was the first cell adhesion molecule to be purified 
and characterized (Brackenbury et al., 1977; Thiery et al., 1977). These early studies 
formed the basis for future CAM discoveries and there are great number of studies on the 
NCAM functions. The NCAM´s N-terminal extracellular part consists of 5 Ig domains and 
2 fibronectin type III (FNIII) domains. Differential splicing causes three major NCAM 
forms to exist: GPI-anchored NCAM-120kD, short cytoplasmic tail NCAM-140kD and 
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long cytoplasmic tail NCAM-180kD. The NCAM function in cell adhesion is homophilic 
in character and the mode of function is still controversial but homophilic action through 
the Ig-domains is generally regarded as being important (Kiselyov et al., 2005). Despite 
the wide expression pattern of the NCAMs during CNS development it is surprising that 
the NCAM deficient mice are viable and have only minor defects in brain development 
and behavior (Cremer et al., 1994). Interestingly, mice that only express the soluble 
extracellular form of the NCAM are embryonically lethal and this result suggested that the 
NCAM could also have heterophilic interactions (Rabinowitz et al., 1996). One important 
heterophilic interaction partner was found to be the fibroblast growth factor receptor 
(FGFR), which was shown to be the signaling molecule for the NCAM induced neurite 
outgrowth (Williams et al., 1994). The FGFR site involved in binding to NCAM has been 
mapped to the FGFR Ig2-Ig3 module, whereas the corresponding site in NCAM that binds 
to FGFR has been mapped to the two FNIII domains (Kiselyov et al., 2003; Kochoyan et 
al., 2008). Mice deficient of NCAM were found to have decreased phosphorylation of the 
FGFR in the brain and this diminished FGFR signaling was restored by giving a peptide 
that mimicks the NCAM binding to FGFR (Aonurm-Helm et al., 2010), which pointed out 
to the importance of the NCAM/FGFR interplay. 
A very interesting feature of NCAM biology is the unique NCAM glycan 
structure called polysialic acid (PSA). The PSA molecule is a linear chain of α2,8-
glycosidically linked N-acetylneuraminic acid residues of different lengths from 8 up to 90 
sugar units. PSA comprises about 10% of protein bound neuraminic acids found in the 
developing brain and almost all is linked to NCAM (Finne, 1982; Galuska et al., 2008). 
The function of PSA decoration for NCAM is to regulate the adhesiveness of homophilic 
and heterophilic interactions of NCAM (Hildebrandt et al., 2007). 
 
4.1.3.3.2 RAGE 
Receptor for advanced glycation end products (RAGE) is composed of three extracellular 
Ig domains, a transmembrane domain and a short cytoplasmic tail (Neeper et al., 1992). 
RAGE is a multiligand receptor that can bind various non-related molecules such as 
advanced glycation end products (Schmidt et al., 1992), HMGB1 (Hori et al., 1995), S100 
(Hofmann et al., 1999), amyloid-beta peptide (Yan et al., 1996) and DNA (Sirois et al., 
2013). This binding pattern of many diverse ligands resembles that seen in toll-like 
receptors, and RAGE is now thought to be one of the pattern-recognition receptors in 
innate immunity (Ibrahim et al., 2013). RAGE signaling activation has been linked to 
various pathological situations such as diabetic complications (Matsumoto et al., 2008b; 
Wendt et al., 2003), cancer (Sasahira et al., 2005; Taguchi et al., 2000) and Alzheimer´s 
disease (Yan et al., 1996). 
 The expression of RAGE in adult tissues is generally low though the only 
exception is the lung where RAGE is highly expressed (Brett et al., 1993). However, 
during brain development RAGE is seen to be expressed together with its ligand HMGB1. 
In experiments in vitro HMGB1 promotes neurite outgrowth of rat neurons that can be 
blocked by soluble RAGE or by anti-RAGE antibodies, which suggests that RAGE 
signaling is able to induce neurite outgrowth (Hori et al., 1995). Later on it was shown that 
the ligation of RAGE with HMGB1 and also with S100 family proteins induces the 
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rac/cdc42 signaling (Huttunen et al., 1999; Huttunen et al., 2000). Recently, it has been 
shown that RAGE can also bind to itself and to promote homophilic cell adhesion, which 
suggests that RAGE could additionally have more commonplace cell adhesion functions 
(Sessa et al., 2014). 
 
4.1.3.4 Leucine-rich repeat proteins 
The leucine-rich repeat (LRR) motif is a protein structure found in all major branches of 
living organisms. The evolution of this motif is relatively unknown and it is suggested that 
the LRRs found in prokaryotes and eukaryotes are an example of convergent evolution 
during which motif evolved independently. The common feature of LRR motif is the 
sequence where the hydrophobic amino acid leucine is placed orderly in the amino acid 
sequence varying from 20 to 30 residues length. All LRR units can be divided into a 
highly conserved segment and a variable segment. The conserved segment consists of an 
11 residue stretch, LxxLxLxxNxL, or a 12 residue stretch, LxxLxLxxCxxL, in which "L" 
is leucine, isoleucine, valine, or phenylalanine, "N" is asparagine, threonine, serine, or 
cysteine, and "C" is cysteine, serine or asparagine. One LRR motif is formed from beta-
sheet-turn-alpha-helix structure, which is held together by hydrophobic interactions from 
side chains of mainly leucine but also of valine and isoleucine. The structural LRR domain 
is formed from 2-45 LRR motifs, which are arranged so that all the beta-sheets and the 
alpha-helices are parallel to a common axis that results in a nonglobular, horseshoe or arc-
shaped molecule. The concave face of the LRR domain is lined with beta-sheets whereas 
the convex face is made from alpha-helices. The primary function of the LRR domain is to 
provide a versatile structural framework for protein-protein interactions (Enkhbayar et al., 
2004; Kajava, 1998; Kobe and Deisenhofer, 1994; Kobe and Kajava, 2001). 
  
 
 
Figure 1. Examples of Leucine-Rich Repeat domains: Rna1p (Hillig et al., 1999) and Decorin 
dimer (Scott et al., 2004). 
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Mammalian LRR proteins can be found in the reducing environment that exists inside the 
cells because the self-assembly of the LRR domain does not need cysteine bridges to 
form. The extracellular LRR domains are usually flanked at both ends by two unique 
cysteine-rich motifs called the LRR N-terminal (LRRNT) and the LRR C-terminal 
(LRRCT) domain. These capping domains are needed to bury the hydrophobic core of the 
LRR domain but in many cases both LRRNT and LRRCT are integral parts of the protein 
that gives additional surface for interactions (McEwan et al., 2006). Many extracellular 
LRR domains containing proteins also have Ig and/or fibronectin (FN) domains but in this 
review proteins are categorized as LRR proteins based on the LRR domain with or 
without other protein domains.  
 
4.1.3.4.1 Neuronal LRR proteins in cell adhesion 
LRR proteins expressed in the CNS are nowadays recognized as a very important family 
of proteins involved in both the development of the CNS with correct connections and 
also in the maintenance of an orderly functioning adult CNS. The Slit family (Slit1, Slit2 
and Slit3) are a well-studied group of LRR proteins involved in vertebrate brain 
development. The Slit proteins are extracellular secreted matrix proteins that have four 
separate LRR domains, of which domain two is needed for the Slit binding to its cell 
surface receptor Robo (Howitt et al., 2004; Kidd et al., 1999). Slit-Robo signaling was 
first found in Drosophila and this signaling is a highly conserved system in bilaterians in 
which the axons cross over to the opposite side of the body to find the proper targets. 
During the CNS development axons travel through the midline and should no longer turn 
back, and Slit was found to be one of the molecules to make this barrier for “not turning 
back”. The binding of the axonal Robo to the matrix bound Slit repels the growth cone 
from the midline and thus keeps the axon on the correct side of the body plane. Slit is a 
soluble extracellular matrix LRR protein. The focus in this review however, is on the cell 
surface transmembrane proteins that have the extracellular LRR domain with neurite 
outgrowth promoting functions. 
 
4.1.3.4.1.1 NGL family 
The first cloned member of the Netrin-G Ligand (NGL) family was Netrin-G Ligand-1 
(NGL-1). NGL-1 was obtained by cDNA library screening in the form of a ligand to a GPI 
anchored Netrin family member Netrin-G1 (Lin et al., 2003). The NGL family contains 
three members (NGL-1, NGL-2 and NGL-3) of type-I transmembrane proteins, all of 
which share a similar structure with an extracellular LRR domain (9 LRR motifs) and one 
C2 type Ig domain. The short cytoplasmic tails of the family members all have a C-
terminal PDZ-binding motif (Kim et al., 2006). It was later shown that NGL-2 binds the 
second member of the Netrin-G family called Netrin-G2. Interestingly, NGL-1 only 
interacts with Netrin-G1, whereas NGL-2 only binds Netrin-G2. However, NGL-3 differs 
from the other NGL proteins in its binding specificity to the receptor tyrosine 
phosphatases LAR (Woo et al., 2009), PTPdelta and PTPsigma (Kwon et al., 2010). The 
expression pattern of the NGL family is mainly restricted to the brain, which suggests that 
these proteins are important for brain development and function. The substrate bound 
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NGL-1 promotes neurite outgrowth in cell culture and in vivo injection of soluble NGL-1 
prevents growth of thalamic axons of chick embryo. The only available knockout mouse 
line regarding this protein family is the NGL-2 deficient mouse. The main findings for this 
knockout model were disordered synapse formation in the hippocampus and retina along 
with axonal pathfinding problems in the outer retina (DeNardo et al., 2012; Soto et al., 
2013). Much of the interest in the NGL family is centered on their function in synapse 
formation where they mediate binding with the cytoplasmic PDZ motif to the postsynaptic 
scaffolding protein PSD-95 (Kim et al., 2006). 
 
4.1.3.4.1.2 SALM family 
Synaptic Adhesion-Like Molecule (SALM) family consists of five members of type-I 
transmembrane proteins characterized by an extracellular LRR domain (5 LRR motifs), 
one C2 type Ig domain and one FNIII domain followed by a short cytoplasmic tail that 
ends at a PDZ-binding motif in SALM1-3. However, this PDZ binding motif is missing in 
SALM4 and SALM5. The expression pattern of the SALM family members suggests their 
important role in CNS development and function because all members are highly and 
specifically expressed in brain except SALM3, which is expressed at low levels in some 
other tissues (Morimura et al., 2006; Wang et al., 2006). Overexpression of SALMs in 
cultured hippocampal neurons (DIV 4–6) increases neurite outgrowth whereas an antibody 
directed at the extracellular part of the SALMs suppresses neurite outgrowth (Wang et al., 
2008). In adult tissue SALMs are mainly located in the excitatory synapses and SALM1-3 
have been shown to interact through their PDZ motifs with the postsynaptic scaffolding 
protein PSD-95. In synaptogenesis SALM1 can directly interact with the NMDA receptor, 
whereas SALM2 associates with both NMDA and AMPA receptors (Ko et al., 2006). 
SALM4 and SALM5 do not have the PDZ motif and thus lack PSD-95 binding properties 
but they also differ from the other SALMs due to their ability to form homophilic trans 
interactions between adjacent cells. In contrast, SALM1-3 are able to interact 
homophilically and also heterophilically between the family members but this interaction 
only happens in a cis manner on the same cell (Seabold et al., 2008). The in vivo functions 
of the SALM proteins remain to be uncovered in future when the first studies of the 
SALM deficient mice are available. 
 
4.1.3.4.1.3 Slitrk family 
The Slitrk family was named and cloned in silico due to its similarity with both the Slit 
and Trk receptor –families. The Slitrk family consists of six members (Slitrk-1 to Slitrk-6) 
of type-I transmembrane proteins that have two extracellular LRR domains and each LRR 
domain is composed of six LRR motifs. The cytoplasmic tail length varies in lenght from 
55 to 300 amino acids and the most distal part of the C-terminus contains a region on 
which a tyrosine residue is flanked by a sequence homologous to the Trk receptor C-
terminus. In the Trk receptors this tyrosine residue is phosphorylated which suggests that 
the Slitrks are similarly regulated. The Slitrk-1 differs from the other Slitrks due to 
truncated cytoplasmic tail that lacks the homology region to the Trk receptors (Aruga and 
Mikoshiba, 2003). The Slitrk family is highly and broadly expressed in the CNS and only 
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Slitrk-6 is additionally expressed in other tissues (Aruga, 2003). Different combinations of 
the family members are expressed in various brain areas, which suggests that each Slitrk 
family member has its own role in the development and maintenance of the highly ordered 
CNS. Overexpression of Slitrk-1 in vitro in mouse cortical neurons resulted in enhanced 
neurite outgrowth (Abelson et al., 2005; Kajiwara et al., 2009) and Slitrk-1 deficient mice 
displayed anxiety-like behavioral symptoms (Katayama et al., 2010). The Slitrk-6 
deficiency in mice leads to diminished neurite outgrowth and innervation of the cochlear 
in the inner ear (Katayama et al., 2009). The Slitrk-5 knockout mice also have a reduced 
innervation phenotype specifically in the striatum, which was suggested to lead to 
obsessive-compulsive–like behaviors in mice (Shmelkov et al., 2010). A very important 
finding came from the Slitrk-3 deficient mice, which had a decreased inhibitory synapse 
number and increased seizure susceptibility due to a lack of trans-synaptic interaction 
between the slitrk-3 and receptor tyrosine phosphatase PTPdelta. That same study showed 
that all Slitrk family members can bind to PTPdelta, which makes PTPdelta the first 
known ligand for this protein family (Takahashi et al., 2012).  
 
4.1.3.4.1.4 LRRTM family 
Leucine-Rich Repeat TransMembrane neuronal (LRRTM) family was cloned in silico due 
to the similarity with the Slit proteins. The LRRTM family consists of four members 
(LRRTM1 to LRRTM4) of type-I transmembrane proteins, which have an extracellular 
LRR domain (10 LRR motifs) followed by a short cytoplasmic tail that ends at the PDZ-
binding motif. All LRRTMs are predominantly expressed in the neurons of the CNS, with 
specific temporal and spatial expression patterns in different brain regions. These 
expression patterns suggest an important role in the development and maintenance of the 
CNS (Lauren et al., 2003). Neurite outgrowth and synapse formation are fundamental 
mechanisms for making a framework for the CNS functions, and the same cell adhesion 
molecules are often involved in both functions. The neurite outgrowth functions for the 
LRRTM family have not been studied yet although this protein family has been 
extensively linked to synapse formation. The first seminal studies of the association of 
LRRTMs with synapse formation came from unbiased screening for finding synaptogenic 
proteins, which suggests that all LRRTMs could promote presynaptic differentiation in 
contacting axons (Linhoff et al., 2009). Further support for synaptic functioning came 
from the findings that LRRTM1 and LRRTM2 are receptors for important presynaptic 
proteins called neurexins, and that this interaction cooperately drives the development of 
the glutamatergic synapses (de Wit et al., 2009; Ko et al., 2009; Siddiqui et al., 2010). 
More evidence accumulated in studies of LRRTM1 knockout mice, which have reduced 
hippocampus size and also reduced synaptic density. The LRRTM1 deficiency in mice 
leads to impaired cognitive functions and claustrophobia-like behavior (Takashima et al., 
2011; Voikar et al., 2013). LRRTM3 and LRRTM4 are more homologous to each other 
than to either LRRTM1 or LRRTM2. An interesting finding was that LRRTM3 and -4 
share unique binding properties to the heparan sulfate proteoglycan family glypicans. The 
glypicans bind to LRRTM3 and -4 through their heparan sulfate chains and this trans-
synaptic interaction regulates excitatory synapse development. In the LRRTM4 knockout 
mice the lack of the LRRTM4 leads to deficient excitatory synapse development and 
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impaired excitatory transmission in the dentate gyrus granule cells (de Wit et al., 2013; 
Siddiqui et al., 2013). A more detailed picture of this important protein family will 
eventually emerge when detailed studies of the LRRTM2 and LRRTM3 deficient mice are 
available. 
 
 
 
Figure 2. Schematic view of neuronal LRR protein families. LRRNT; leucine-rich repeat N-
terminal capping domain, LRRCT; leucine-rich repeat C-terminal capping domain, LRR; leucine-
rich repeat motif, IG-domain; immunoglobulin domain, FNIII; fibronectin type III domain, TM –
domain, transmembrane domain. 
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4.2 Electrochemical communication 
In electrochemical communication two kinds of signaling worlds are combined together 
and the CNS is the place where this shift from electricity to chemistry (and vice versa) has 
evolved in superiority. The electrical signal for communication travels through neurites in 
a form of ionic flow through specific pores called “voltage-gated ion channels” on the cell 
membrane. When electrical signal travels to the site called the synaptic cleft that is located 
between two separate neurons, the signal is changed to a chemical in the form of 
neurotransmitters, which travel to the oppose side of the cleft by diffusion. On the adjacent 
cell the transmitter binds to a specific receptor that in turn propagates the signal in electric 
or chemical form depending on the receptor type the cell expresses. The focus in this 
review is on ion channels that are activated by voltage and are named as voltage-gated ion 
channels. 
 Voltage-gated ion channels are plasma membrane spanning proteins that 
make a regulated pore for ions to travel according to their electrochemical gradient. 
Regulation of the pore opening for ions is driven by specialized protein structures, which 
sense the voltage difference across the plasma membrane. 
 
4.2.1 NaV 
Voltage gated sodium currents were first discovered by Hodgkin and Huxley in their 
pioneering work using the voltage clamp method (Hodgkin and Huxley, 1952). Voltage 
gated sodium channels (NaVs) are responsible for the initiation and propagation of the 
action potentials and are vital for normal neuronal signaling. The NaVs are made of two 
distinctive polypeptides, which are the alpha and the auxiliary beta subunits. In mammals 
the NAV alpha subunit protein family consists of nine members, and each alpha unit is a 
large polypeptide that contains four homologous transmembrane spanning regions. On the 
plasma membrane the alpha subunit assembles to form a specific pore for the sodium ions 
and this unit also contains the necessary structures for regulation of the pore opening. The 
auxiliary beta subunit is a single-pass type-I transmembrane protein that regulates the 
alpha subunit´s gating properties, protein expression profile and linking of the alpha 
subunit to the cytoskeleton and the ECM (Catterall, 2000a). One interesting finding 
regarding the beta subunits is that they are heavily glycosylated with negatively charged 
sialic acids. This negative charge brought by the beta subunit is needed for optimization of 
NaVs functioning to sense differences in the membrane potentials. The alpha unit itself 
also contains sialic acids for tuning the gating properties (Johnson and Bennett, 2006; 
Johnson et al., 2004). The NaVs can also be modulated through the phosphorylation of 
specific residues on the alpha subunit, which takes place after the activation of the 
cytoplasmic protein kinases. The phosphorylation effect on different alpha subunit 
members can vary from an increase to a decrease of the current amplitude (Chahine et al., 
2005). Various knockout mouse models are available to study different NaV alpha and 
beta subunits. A common feature for these knockout models is a susceptibility to epileptic 
seizures, which is thought to be caused by discoordinated firing patterns of the neurons. 
This indicates the importance of the NaVs in normal CNS functions. 
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4.2.2 CaV 
Voltage-gated calcium channels (CaVs) differ from other voltage-gated ion channels 
because they are less involved in the propagation of action potentials but they do have a 
unique role in bridging the electrical signal its chemical counterpart. Calcium ion (Ca
2+
) 
functions in biology as an important second messenger in a myriad of different cellular 
events. The Ca
2+
 concentration inside the cytosol in neuronal tissue is one-thousandth that 
of the outside. This large electrochemical concentration difference is utilized by the CaVs 
which open due to the polarization of the membrane during the action potential. This leads 
to the initiation of the synaptic transmission in the synaptic terminals through the second 
messenger Ca
2+ 
(Catterall, 2011). The main structural component of the CaVs is the pore 
forming alpha unit. In vertebrates there are nine different CaV alpha unit genes, which are 
expressed differentially in various tissues. The structure for the CaV alpha unit shares a 
similar evolutionally related structure to that of the NaVs, whereby the CaV alpha unit is 
formed from a large polypeptide with four homologous repeats each of which have six 
transmembrane helices. Self-assembly of this polypeptide on the cell membrane forms a 
specific Ca
2+ 
permeable pore that opens depending on voltage (Catterall, 2000b). The CaV 
functions are also regulated by auxiliary subunits that belong to three separate protein 
families called: CaVbetas, alpha2deltas and gammas. The functions of these auxiliary 
subunits vary from the regulation of CaV alpha unit surface expression to gating 
properties (Arikkath and Campbell, 2003). Many CaV alpha or auxiliary subunit deficient 
mouse models are available in which many neurological human diseases related to the 
CaVs are recapitulated. A common feature of CaV deficiency is ataxia and a susceptibility 
to seizures (Benarroch, 2010). 
4.2.3 KV 
The canonical view for voltage gated potassium channel (KV) currents is that they are the 
counterpart for the voltage gated sodium currents during action potential propagation. The 
KVs opens to repolarize the membrane potential closer to potassium ion equilibrium and 
further away from the action potential firing threshold upon the action potential 
depolarization. This function renders the KVs as the primary regulators for the patterns of 
action potential firing. Forty members of the KV protein family have evolved in 
mammals, which indicates the importance of these ion channels for the correct functioning 
of the CNS. The principal alpha subunits of the KVs are coded by genes from 12 
subfamilies, KV1 through KV12 (Gutman et al., 2005). The kinetics of the voltage-gated 
properties between the KV members varies considerably and the combination of the KV 
members expressed by the cell shapes the action potential frequency and patterning in that 
particular cell type. The KVs are formed from four individual subunits in each of which 
contains six transmembrane helices. The N- and C-termini face the cytoplasm. These 
subunits then self-assemble to form the voltage sensing structure and the regulated pore 
for the potassium ions. Interestingly, the Kv1-Kv4 subfamilies can form either homomeric 
or heteromeric, functional tetrameric channels which increase further the possible KV 
current repertoire of the cell. This membrane-spanning segment structure in KVs is 
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homologous to the NaVs and the CaVs. The KVs are formed from four separate proteins, 
whereas in the NaVs and the CaVs these four separate parts have merged into one 
entity/gene. This difference between the KVs and the NaVs/CaVs suggest that the KVs are 
evolutionally older and, the NaVs and the CaVs have evolved later from the KVs 
(Anderson and Greenberg, 2001). 
 When neuronal voltage-gated potassium currents are recorded one can find 
two distinct currents: Fast transient peak current IA is fast activating and fast inactivating, 
whereas the delayed rectifier current IK is more slowly activating and very slowly 
inactivating or non-inactivating (Mathie et al., 1998). Both IA and IK counteract the NaV 
currents by repolarizing the action potential back to the resting potential. The fast transient 
IA currents play an important role in controlling the action potential durations, and both IA 
and IK regulate how often and at which frequency the neuron fires the action potentials 
(Yuan et al., 2005). The exact in vivo role of the single channel type has been difficult to 
verify because one neuron can express many different KV alpha units with overlapping 
voltage-gating kinetics. A big hindrance is the lack of specific pharmacological tools to 
specifically block certain KVs. For example, in vivo studies that use mouse knockout lines 
have the problem of potential compensation for the loss of one KV by altered expression 
of a related KV (Foehring, 2008). 
 Many KV alpha units undergo post-translational modification including 
phosphorylation and glycosylation and are regulated by auxiliary units. The 
phosphorylation effect for the KVs can be manifest as a decrease in current amplitude 
(Macica et al., 2003) to a depolarizing shift in gating kinetics (Schrader et al., 2006; 
Winklhofer et al., 2003). The KV alpha units are usually decorated with negatively 
charged sialic acids, which change the KV gating properties to more negative values 
(Schwetz et al., 2010; Schwetz et al., 2011; Thornhill et al., 1996). Such a sialic acid 
function resembles equivalent changes seen in the NaVs. Various intracellular and 
transmembrane proteins associate as auxiliary subunits with the KV alpha units. The best 
known auxiliary subunits are the KV beta subunit family together with the KCNE family. 
The KV beta subunits are intracellular proteins that regulate the KV1 family of alpha 
units. The effect of certain beta subunits can be subtle or very profound, such as in the 
case of Kv1.1 whereby the binding of the KV beta1 changes the channel from the IK 
current to IA. The KCNE family members are type 1 transmembrane proteins that regulate 
the current density and gating kinetics of the KV alpha unit by interacting with alpha units 
through the transmembrane domain (Li et al., 2006; Sun et al., 2012).  
 
4.2.3.1 Kv2.1 
Kv2.1 was cloned in 1989 from the rat brain as the gene that encodes the mammalian 
counterpart of the Drosophila Shab channel (Wei et al., 1990). When this cDNA was 
expressed in a Xenopus oocyte the result was a typical delayed rectifier IK current (Frech et 
al., 1989) Histology analysis revealed the channel to be localized specifically to neurons 
for which the channel had a unique punctate staining on the cell soma (Trimmer, 1991). 
When another evolutionally related KV was cloned (Hwang et al., 1992) it was evident 
that in the mammalian brain two similarly functioning IK channels exist that are now 
called Kv2.1 and Kv2.2 (Maletic-Savatic et al., 1995).  
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 The structure of Kv2.1 is unique compared to other KV alpha units due to its 
large cytosolic N- and C-termini that have 123 possible residues for phosphorylation. The 
phosphorylation status of Kv2.1 has been under extensive investigation during recent 
years. Kv2.1 was shown to be heavily phosphorylated both in vitro in heterologous COS-1 
cells and in vivo in rat brain membranes. Interestingly, Kv2.1 attained the high 
phosphorylation status rapidly during pulse chase labeling, which suggests that this 
phosphorylation pattern is important for properly functioning Kv2.1 (Shi et al., 1994). 
Shortly after a study (Murakoshi et al., 1997) showed that the phosphorylation stage of 
Kv2.1 regulated the voltage-gated properties of the channel because dephosphorylation of 
Kv2.1 led to a hyperpolarizing shift in the channel opening. Surprisingly, the characteristic 
staining pattern of the Kv2.1 was also regulated by phosphorylation. Kv2.1 localizes on 
cell plasma membrane in ring like clusters which are above specialized endoplasmic 
reticulum structures called subsurface cisterns (Du et al., 1998). When Kv2.1 is 
dephosphorylated in vitro and also in vivo due to certain treatments that mimick ischemia 
or hyperexcitability, the Kv2.1 clusters dissociate and the Kv2.1 channels diffuse across 
the plasma membrane (Misonou et al., 2005a; Misonou et al., 2004). These 
dephosphorylation changes both in gating and localization of Kv2.1 are suggested to be 
important for the Kv2.1 function as a homeostatic regulator of neuronal excitability. When 
a neuron fires action potentials at high frequency the Kv2.1 role is to inhibit the possibility 
for the action potential reoccurrence, and simultaneously the Kv2.1 activity reduces the 
firing rate. Dephosphorylation of Kv2.1 happens during the repetitive firing of the action 
potentials, and this leads to a hyperpolarizing shift in the Kv2.1 gating properties, which 
makes Kv2.1 an even more potent suppressor of the high frequency firing. The cell 
“remembers” the high activity state of the past because the dephosphorylated state of 
Kv2.1 persists for a while and this phenomenon resembles homeostatic plasticity 
(Misonou et al., 2005b). 
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5 Aims of the study 
The aim of the study was to find a novel gene that is specifically expressed in the CNS 
that is involved in neurite outgrowth and CNS development, then to study the role of that 
novel gene on molecular and whole animal levels: 
 
1. to find and clone a novel gene in rat hippocampal neurons that is induced by 
HMGB1-promoted neurite outgrowth 
 
2. to characterize the expression pattern of the novel gene/protein (later named 
AMIGO) 
 
3. to reveal the in vitro and in vivo role of AMIGO by cell culture methods and by 
creating AMIGO deficient mice 
 
4. to resolve the exact structure of the extracellular part of the AMIGO protein 
 
5. to find interaction partners for AMIGO 
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6 Experimental Procedures 
More detailed information about methods and materials used can be found in the original 
publications. 
 
Table 1. Methods used in the thesis where author was personally involved.  
 
Method Publication 
Acute hippocampal slice preparation IV 
Antibody production I, IV 
Bioinformatics I, III 
Cell culture and transfection I, III, IV 
Chemical cross-linking IV 
Co-immunoprecipitation I, III, IV 
DNA constructs I, III, IV, V 
Electrophysiology IV, V 
Immunocytochemistry I, IV 
Knockout mouse production V 
Lentivirus production and transfection IV 
Microscopy I, IV 
Neuronal cell culture I, IV 
Ordered differential display I 
Recombinant protein production I, III, 
RT-PCR I, V 
Southern blotting V 
Western blotting I, III, IV, V 
 
6.1 Animals 
Mice that were deficient of the Amigo gene were created by using the standard 
homologous recombination method described by Folger et al. (1982). Briefly, homologous 
arms around the mouse Amigo locus were cloned into a targeting vector so that the 
AMIGO protein coding sequence was replaced with the LacZ gene. After electroporation 
of the targeting vector into the mouse embryonic stem (ES) cells, targeted clones were 
found with the help of Southern blotting and PCR techniques. The Amigo targeted ES cell 
clone was introduced into the mice by using an aggregation method, which resulted in 
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chimeric mice that were mated with WT mice to get the first heterozygous Amigo targeted 
mice. The Amigo deficient mice were subsequently backcrossed to C57BL/6JOlaHsd 
background at least 8 rounds before all experiments.   
 
6.2 Primary neuronal cultures  
Rat hippocampal or cortical neurons were dissociated from E17/E18 rat embryos and were 
cultivated in Neurobasal supplemented by B27, L-glutamine and antibiotics. 40 000 
hippocampal neurons per 1 cm
2 
or 80 000 cortical neurons per 1 cm
2 
were plated on 
different substrates as detailed in each experiment. 
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7 Results and Discussion 
7.1 Discovery of AMIGO and its structure (I, II, III) 
7.1.1 Cloning of a novel neuronal cell adhesion molecule  
The aim of this study was to clone novel genes involved in neurite outgrowth on HMGB1 
(Amphoterin) substratum (Rauvala and Pihlaskari, 1987) compared to the more commonly 
used neurite outgrowth-promoting substrate, laminin (Manthorpe et al., 1983). The 
method chosen for finding genes involved in the HMGB1-promoted neurite outgrowth 
was ordered differential display (ODD) as described by Matz et al. (1997). This method 
enabled us to clone a gene whose expression was induced on the HMGB1 substrate, and 
interestingly this induction was also seen on anti-RAGE substratum. RAGE is a known 
cell surface receptor for HMGB1 therefore this result suggested that the induction of the 
gene of interest was due to HMGB1-induced RAGE signaling. The full-length transcript 
was revealed by using the 5´RACE method (Matz et al., 1999), which showed that the 
gene was novel and unpublished. We named the gene Amphoterin-Induced Gene and ORF 
(Amigo). The sequence suggested that the Amigo gene encodes a type-I transmembrane 
protein with a putative signal sequence and a transmembrane region. The N-terminus of 
the AMIGO protein faces outside the cell whereas the C-terminus is located in the cytosol. 
A closer analysis of the protein revealed that the extracellular part of the protein is formed 
from a putative LRR-domain (with 6 LRR motifs) and a single Ig domain. The short 
cytosolic tail (99 amino acids) did not show any known protein motifs but interestingly 
this cytoplasmic part has been well conserved during mammalian evolution. The human 
AMIGO cytosolic part displayed at least 96% similarity with Placential and around 90% 
similarity with Marsupial AMIGO sequences, which suggests some still unknown 
important function for the AMIGO cytosolic tail. The LRR domain of the AMIGO 
resembles their counterparts seen in Slit (Whitford et al., 2002) and the Nogo receptor 
(Fournier et al., 2001) protein families. In contrast, the Ig domain of the AMIGO showed a 
similarity to PFAM software defined immunoglobulin V-set motifs that can be found in T-
cell receptors and adhesion junction molecules (Punta et al., 2012). The upregulation of 
the AMIGO during neurite extension combined with the deduced AMIGO protein 
sequence with the LRR and Ig domains suggest a role in cell adhesion and possibly in 
neurite outgrowth. 
 
7.1.1.1 AMIGO defines a novel protein family 
When we used the AMIGO sequence information we also cloned two other novel genes 
homologous to AMIGO, and for convenience we named them: AMIGO2 and AMIGO3. 
The general layout of the AMIGO2 and -3 is the same as in AMIGO and the similarity of 
the amino acid sequences between the AMIGO family members is 50-55%. Certain 
regions in the sequences such as the transmembrane segments, the LRR domains and 
some sequence motifs in the cytosolic tails are more highly conserved. Gene expression 
analysis of the AMIGO family in adult mouse tissues demonstrated that the AMIGO gene 
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is more specifically expressed in the CNS, whereas AMIGO2 and especially AMIGO3 
expression are more widely distributed (Fig. 3A in publication I).  
 When this research work was in progress the Amigo2 gene was shown to be 
induced by neuronal activity and the expression of the AMIGO2 protein promoted 
depolarization-dependent survival of cerebellar granule neurons (Ono et al., 2003). The 
mRNA expression of Amigo2 in mouse CNS has been studied in more detail and Amigo2 
was shown to be specifically expressed in the CA2/CA3 area of the hippocampus 
(Laeremans et al., 2013). Amigo2 has been also shown to be a differentially expressed 
gene in gastric adenocarcinoma tumors (Rabenau et al., 2004). AMIGO3 has recently been 
shown to be a co-receptor of NgR1/p75 complex that is involved in myelin-induced axon 
growth inhibition (Ahmed et al., 2013).  
 
 
 
 
 
Figure 3. Alingment and schematical view of the AMIGO family members 
 
 
  
28 
 
7.1.2. AMIGO crystal structure 
Recombinant mouse AMIGO extracellular domain was produced in large quantities in 
Drosophila Schneider 2 cells (Schneider, 1972) and after a series of optimizations 
AMIGO crystals were formed in 0.1 M 4-morpholineethanesulfonic acid, pH 6.5, and 
1.6M MgSO4. The quality of the AMIGO crystals allowed us to determine the AMIGO 
extracellular structure at 2 Å resolution. The structure of the AMIGO ectodomain 
followed the prediction made in silico by sequence homology with one LRR domain and 
one Ig domain. The striking feature was that AMIGO crystallized as a dimer such that the 
concave face of the LRR domain was responsible for the dimer interface.  
 
 
Figure 4. AMIGO dimer where the two AMIGO proteins depicted are interacting through the LRR 
domain. One AMIGO is pictured as a space filling model and the other as a ribbon model. 
 
7.1.2.1 Dimer formation is needed for AMIGO secretion 
The exact structure of AMIGO allowed us to pinpoint the important amino acid residues 
that interact on two separate AMIGOs to form a dimer. Eight residues where chosen from 
the dimer interface for mutational analysis and for control purpose one residue was chosen 
outside the area. The idea was to produce these recombinant proteins with residues 
mutated to alanine and study the possible dissociation constant (Kd) value differences 
between these mutants. We found to our surprise, that the mutation of all eight important 
dimer interface residues led to impaired secretion of the recombinant AMIGO protein, 
whereas the control mutation close to the interface did not result in any effect (Fig. 7 in 
publication III). The AMIGO interface mutants were presumably detected by the quality 
control machinery of the endoplasmic reticulum (ER) and were thus prevented from 
exiting the ER (Ellgaard and Helenius, 2003). This result suggests that correct dimer 
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interface formation is needed for the proper folding of the AMIGO dimer, and without this 
dimerization AMIGO is misfolded and discarded from the pathway that directs AMIGO to 
the plasma membrane. 
7.1.2.2 AMIGO is heavily glycosylated 
The analysis of the AMIGO sequence predicted (Lutteke et al., 2006) five possible N-
glycosylation sites, and indeed some of these were already occupied by N-glycosylation in 
the AMIGO crystals. The AMIGO crystals were formed from recombinant protein 
expressed in Drosophila therefore we had to study the N-glycosylation of AMIGO in 
mammalian cells to prevent the possible effects of N-glycosylation differences between 
insects and mammals from obscuring our results (Altmann et al., 1999; Tomiya et al., 
2004). We mutated the five possible N-glycosylation sites predicted in the mouse AMIGO 
with alanine (N72 and N269 on LRR domain, N315, N348 and N359 on Ig domain). 
These mutations together with the wild type (WT) AMIGO were transiently expressed in 
HEK293 cells and the total cell lysates were subjected to Western blotting using an anti-
AMIGO antibody. The result showed that all the five predicted N-glycosylation sites of 
the AMIGO were occupied (Fig. 3 in publication III). The exact role of the N-
glycosylation on the AMIGO protein surface is not yet known but interestingly four of the 
N-glycosylation sites (N269 on the LRR domain, N315, N348 and N359 on the Ig 
domain) have been conserved during the evolution from teleost (zebrafish) to mammals. 
The Ig domain has three N-glycosylation sites, and we suggest that these sugars help to 
orientate the LRR domain properly on the plasma membrane. Further, the N-glycosylated 
AMIGO was found to contain complex glycans with negatively charged sialic acids (Juha 
Kuja-Panula unpublished result). 
 
7.1.2.3 All AMIGO family members are dimers 
The AMIGO structure allowed us to model the structure of the other members of the 
AMIGO family. The modelling together with the analysis of gel filtration and small-angle 
X-ray scattering (SAXS) results suggested that both AMIGO2 and AMIGO3 are dimers. 
The sequence alignment of the ectodomains of the three AMIGOs showed that the site of 
the dimer interface on the AMIGO surface was conserved between the AMIGO family 
members, which also gave additional support for the dimer formation for the AMIGO2 
and -3 (Fig. 4 in publication III). The SAXS data also revealed that AMIGO2 differs from 
AMIGO and AMIGO3 in having a more elongated dimer, which is possibly due to a 
longer linker sequence between the LRR and the Ig domain. The dimer interface 
conservation between the AMIGO family members suggests that the AMIGOs could form 
dimers with each other. 
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7.2 Role of AMIGO in developing CNS (I, II, III) 
The expression pattern of the Amigo gene was studied in more detail in 
mouse embryos (embryonic day 13; E13) and in adult mouse brain sections by using 
mRNA in situ hybridization. In the E13 embryos the Amigo gene was expressed strongly 
in the developing dorsal root ganglia and in the trigeminal ganglion. In the adult mouse 
brain, the expression was widely distributed (Fig. 3B in publication I). The same protein 
family was also found in zebrafish (ZF, Danio rerio) which suggests that the ancestral 
AMIGO protein evolved 450 million years ago before early tetrapods diverged from the 
teleost linage (Soltis and Soltis, 2012). The ZF AMIGO family differs from its 
mammalian equivalent in that the ZF family lacks the AMIGO2 counterpart instead it has 
two variants of AMIGO3 called -3a and -3b (publication II). Amigo is the predominant 
AMIGO family transcript in the whole ZF larvae. Its expression rises after two days post 
fertilization (dpf) and continues to rise during early development (Fig. 1B in publication 
II). AMIGO protein staining could be clearly seen in the larval brain at 28 hour post 
fertilization (hpf). The AMIGO protein was found to be localized both in the neuronal 
progenitor cell layers and in the early developing fiber tracts. The staining in the fiber 
tracts could be seen on the leading front and along the fascicles on the medial longitudinal 
fascicle (MLF) and on the post-optic commissure (POC). 
 
7.2.1 AMIGO in neurite outgrowth and fasciculation  
The original method for finding AMIGO and its expression pattern suggested a role in 
neurite outgrowth. Indeed, when rat hippocampal neurons were plated in vitro onto the 
AMIGO extracellular matrix neurite outgrowth was evident after 24 hours compared to the 
control situation (Fig 6 in publication I). When in vitro hippocampal neurons were plated 
on poly-L-lysine matrix for four days, neurites started to form bundles in a phenomenon 
called fasciculation (Rutishauser and Edelman, 1980) whereby neurites grow alongside 
each other by using pioneer axons as the substratum for their growth cones. Interestingly, 
the addition of the AMIGO ectodomain into the culture medium inhibited the formation of 
the neurite bundles which suggests that AMIGO has a role in neurite fasciculation (Fig. 7 
in publication I). The same role of the AMIGO in fasciculation was also revealed in vivo 
in the developing zebrafish CNS where the knockdown of endogenous AMIGO or the 
dominant negative approach using the AMIGO ectodomain resulted in disturbed 
fasciculation of the MLF and POC fiber tracts, which are also the places where AMIGO is 
higly expressed during ZF CNS development (publication II). 
 
7.2.2 AMIGO family proteins display homophilic interactions 
The results from both neurite outgrowth and fasciculation assays guided us to study 
possible mechanisms of AMIGO in these two phenomena. We carried out co-
immunoprecipitation assays in heterologous HEK293T cells with two differentially tagged 
variants of AMIGO (GFP- or V5-tag). The same procedure was also used for AMIGO2 
and AMIGO3. An unrelated transmembrane protein RAGE was tagged with the V5 
sequence for control purposes. The HEK293T cells were transiently transfected with all 
  
31 
 
possible combinations of the GFP and V5 tagged proteins, and were then subjected to co-
immunoprecipitation with anti-GFP or anti-V5 antibodies. Western blotting of the samples 
showed that the AMIGO-GFP could be pulled down by the AMIGO-V5 variant, which 
suggests that the AMIGO molecule possess homophilic interaction capabilities. The same 
was also true for AMIGO2 and AMIGO3, which also proved to be homophilic although 
no interaction was seen with the control protein RAGE. Interestingly, the AMIGO family 
members display heterophilic binding properties with each other. The homophilic 
interaction of the AMIGOs was further characterized by using a bead aggregation assay 
(Fig 8 in publication I). These findings along with those of the crystal structure of the 
AMIGO suggest that the defasciculation seen with a dominant negative approach in both 
mice and zebrafish are due to the inhibition of homophilic binding of the AMIGOs 
between adjacent neurites. These results allow the categorization of the AMIGO family 
members as cell adhesion molecules (CAMs), which are a group of proteins whereby 
many members possess homophilic interaction properties. 
 
 7.2.3 Could AMIGO make trans-homodimers between cells? 
The AMIGO matrix promoted neurite outgrowth and the soluble AMIGO was able to 
prevent fasciculation of the neurites. Could these results implicate that AMIGO works as a 
homophilic cell adhesion molecule between two separate cells in trans orientation? The 
AMIGO dimer as seen in the crystal structure was released from the ER in cis orientation 
to the plasma membrane, and this dimer should be opened to allow two AMIGO 
molecules to meet each other in trans-orientation and to dimerise. The conclusion from the 
SAXS data (publication III) suggested this possibility and thus accordingly a role for 
AMIGOs as homophilic cell adhesion molecules. 
 
7.2 Role of AMIGO in adult CNS (II, IV, V) 
7.2.1 AMIGO associates with voltage-gated potassium channel 
Kv2.1  
7.2.1.1 AMIGO co-localizes and interacts with Kv2.1 
When adult mouse CNS and mature in vitro hippocampal neurons were stained by specific 
anti-AMIGO antibody the staining pattern was restricted to the cell soma and to the 
proximal part of the neurites. A closer look of the immunostaining pattern showed that 
AMIGO was concentrated in punctate/ring like clusters (Fig. 1 in publication IV). This 
peculiar staining pattern resembled that seen for the voltage-gated potassium channel 
Kv2.1 (Trimmer, 1991), which belongs to the group of delayed rectifier channels. We then 
double-stained both those neurons in vitro and in vivo with AMIGO and Kv2.1, and they 
showed striking co-localization (Fig.1 in publication IV). The temporal expression pattern 
of AMIGO and Kv2.1 were also similar, and when both were expressed in a heterologous 
system the co-localization was evident. The cell surface localization of Kv2.1 is 
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extensively regulated by phosphorylation whereby dephosphorylation leads to the 
diffusion/dispersion of Kv2.1 around the cell membrane (Misonou et al., 2004; Misonou et 
al., 2005b). Interestingly, when neurons were treated both in vitro and in vivo to induce the 
dephosphorylation of Kv2.1, AMIGO diffused from the cell surface clusters. This 
suggests that AMIGO and Kv2.1 are intimately coupled. This interplay was further 
studied by co-immunoprecipitation experiments in the adult mouse brain and indeed 
AMIGO and Kv2.1 readily pulled down each other whereas the control protein Kv1.2 did 
not show any interaction with AMIGO (Fig. 2 in publication IV).  
We also studied the possibility that the AMIGO-Kv2.1 interaction is 
evolutionarily conserved from fish to mammals. In early the ZF CNS (28 hpf) the co-
localization was not detected, whereas in the adult ZF CNS, the AMIGO and Kv2.1 
association was evident in both tissue co-localization and in co-immunoprecipitation 
experiments (Publication II).  When these results were compared to those of the mouse 
they suggested that AMIGO belongs to the Kv2.1 channel complex and this interaction 
has evolved at least 450 million years ago. 
 
7.2.1.2 AMIGO changes voltage gating properties of Kv2.1 
The results presented above raise the possibility that AMIGO could change the 
electrophysiological characteristics of the Kv2.1 channel. Consequently, we address to this 
question when we used a heterologous system by transiently transfecting HEK293 cells 
together with AMIGO and Kv2.1. A non-related type-I transmembrane protein NCAM 
was also used to transfect the HEK293 cells as a control. An important finding was that 
the voltage-dependent activation of the Kv2.1 shifted to more negative values when 
AMIGO was present, whereas the control protein NCAM did not have any effect on the 
HEK293 cells (Fig. 3 in publication IV). This result was studied further to find the 
important parts of the AMIGO protein that were needed for changing the Kv.21 voltage 
gating. A series of fusion proteins were used whereby the AMIGO extracellular, 
transmembrane or cytosolic domains were swapped with their NCAM counterparts. The 
hyperpolarizing effect of AMIGO on Kv2.1 was totally abolished by using an AMIGO 
variant with the NCAM transmembrane domain. Reduced AMIGO potency was evident in 
variants when the extracellular or cytoplasmic parts were changed to the NCAM 
counterparts (Suppl. Fig 6S in publication IV). These effects suggest that the interaction 
sites for AMIGO and Kv2.1 are located within/on their transmembrane domains whereas 
both the extracellular and cytoplasmic domains contribute to the electrophysiological 
effect through an unknown mechanism that remains to be elucidated. 
 
7.2.1.3 Inhibition of AMIGO in cultured neurons changes voltage-gated 
potassium currents 
After the heterologous overexpression studies we then investigated what happens to 
voltage-gated potassium currents when endogenous AMIGO is inhibited. We used the 
short hairpin RNA method in mature 14-day old in vitro cultured hippocampal neurons. 
Even though hippocampal neurons can contain many different voltage-gated potassium 
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channels, the inhibition of AMIGO significantly decreased the delayed rectifier current IK 
at negative membrane potentials, around the action potential threshold (Fig 4 in 
publication IV). When this same protocol was applied to neurons treated by the specific 
Kv2.1 blocking agent GxTX-1E (Herrington et al., 2006), the voltage-gated potassium 
currents were significantly changed, which revealed that our experimental setup partially 
addressed voltage-gated potassium currents originating from Kv2.1. Those results with 
neurons lacking AMIGO contradicted those of the overexpression situation and this fits 
the hypothesis that AMIGO is indeed an auxiliary unit of the voltage-gated potassium 
channel Kv2.1. 
 
7.2.2 AMIGO deficiency in mice leads to schizophrenia like 
symptoms  
7.2.2.1 AMIGO regulates Kv2.1 protein expression and voltage-gated 
potassium currents  
We produced a mouse line that was deficient in the Amigo gene to study the in vivo 
functions of AMIGO in mammals. Those mice bred normally without any obvious signs 
of problems in the normal caged environment. Moreover, when the brains of the adult 
mice were studied under Luxol fast blue/creysyl violet staining there were no differences 
between the knockout (KO) and wild type (WT) mice. Immunohistochemical staining 
with common markers for neurons and glia also found no obvious phenotypes in these cell 
types in the Amigo KO mice. Histological staining of the adult mouse brain sections with 
the anti-Kv2.1 antibodies however revealed that the intensity for Kv2.1 was clearly 
reduced in the KO mice. We then studied this phenomenon more closely by using Western 
blotting with samples made from adult mouse brain membranes. The reduction of the 
Kv2.1 band intensity in the samples was 45% in the Amigo KO mice compared to their 
WT littermates. The same samples were stained with Kv1.2 as a control, and did not show 
any difference between the genotypes. Similar diminished expression of Kv2.1 was also 
seen in developing ZF CNS (3 dpf) when AMIGO expression was inhibited using 
morpholino oligos (Fig. 5A in publication II). The finding that the Kv2.1 expression is 
reduced in the situation when AMIGO is missing supports the idea that the functions of 
AMIGO and Kv2.1 are intimately associated.  
 The electrophysiological findings in an earlier publication (IV) motivated us 
to see whether there is a difference in voltage-gated potassium currents between the Amigo 
KO and the WT mice. Measurements were made in samples of CA1 pyramidal neurons by 
using acute hippocampal slices obtained from both genotypes. The findings from this 
setup were in agreement with our previous in vitro electrophysiological results. We could 
see a similar reduction in the voltage-gated potassium currents at negative membrane 
potentials around the action potential threshold in the Amigo KO mice compared to their 
WT littermate controls. Even though pyramidal neurons simultaneously express many 
different voltage-gated potassium currents, we suggest that the difference seen in the KO 
mice was due to a lack of AMIGO/Kv2.1 interaction which led to an improperly 
functioning Kv2.1 channel. 
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7.2.2.2 Amigo knockout mice have disrupted complex behavioral traits  
We subjected the Amigo KO mice and the WT littermate to an extensive battery of 
behavioral tests in order to elucidate the possible role of AMIGO in vivo. The Amigo KO 
mice were normal for tests that measured the nociception and motor co-ordination, which 
supported the notion that the Amigo KO mice could not be separated behaviorally from 
their WT controls in routine tests. However, test patterns for studying more complex 
behavioral traits found differences between the KO mice and their WT littermates.  
When mice were placed in the open field test arena it was obvious that the 
Amigo KO mice traveled more (158%) during the test period, which indicated that the 
Amigo KO mice were hyperactive. Interestingly, when the Amigo KO mice and their WT 
littermates were subjected to a low dose of the psychotomimetic drug, MK-801, the 
hyperactivity phenotype was significantly increased in the KO mice, whereas the MK-801 
effect was not evident in the WT mice. A similar hyperactive phenotype was also seen in 
AMIGO deficient ZF larvae (3dpf), which suggests that a lack of AMIGO leads to a 
disruption of an evolutionarily related neuronal function (Fig. 9A in publication II). 
Sensorimotor gating is a phenomenon in which the animal automatically 
filters out non-related information from important information, which allows the animal to 
cope in a complex environment. This system can be found in fish (Burgess and Granato, 
2007) and humans (Adler et al., 1982), thus the measurements of the sensory gating are 
done similarly across all the species using prepulse inhibition (PPI). The PPI measures the 
startle response of the animal in a test chamber in which a weak prestimulus inhibits the 
startle caused by a stronger stimulus. The Amigo KO mice showed significantly reduced 
PPI when compared to WT littermates. Reduced PPI is a common feature found in the 
schizophrenia patients which can be relieved by administration of the antipsychotic drug 
haloperidol (Kumari and Sharma, 2002). When the Amigo KO mice were treated with 
haloperidol we noted a clear rescue effect and their PPI responses shifted to more normal 
values. 
Two different experiments were used in the social behavior testing which 
were: the resident intruder test for the social stress paradigm and the tube test to determine 
dominant and subdominant behavior. In the resident intruder test the Amigo KO mice did 
not differ from the WT littermates, which suggests normal coping by the Amigo KO mice 
for social stress. In the tube test the WT littermates won significantly more trials than the 
Amigo KO mice, which suggests that an AMIGO deficiency leads to subdominant 
behavior. 
The memory consolidation of the Amigo KO mice was initially studied using 
the Morris water maze and the two genotypes were found not to differ from each other. 
We studied memory more closely, by placing the Amigo KO and WT mice in IntelliCage 
(Endo et al., 2011) to measure many spontaneous and memory behaviors in homecage-like 
environment. The versatile analysis properties of IntelliCage method enabled us to find 
memory deficiency in the Amigo KO mice in the task called “patrolling”. In this paradigm, 
a mouse has to learn that the “correct” corner is changed in a clockwise manner after every 
“correct” visit. This memory task is similar to the 8-arm radial maze and both tests 
measure behavioral flexibility and working memory (Too et al., 2013; Weyer et al., 2011).  
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7.2.2.3 Behavioral changes in Amigo knockout mice resemble 
schizophrenia  
Schizophrenia is one of the most common human mental disorders and it affects about 0.7 
% of the world’s population. It is generally believed that this sickness has been disrupting 
the lives of people through the history of mankind even though it was first diagnosed as 
recently as as 1887 by Kraepelin (Engstrom and Weber, 2005). The symptoms for 
schizophrenia are classically divided into two categories: positive and negative symptoms. 
The positive symptoms could be called “gain of function” symptoms whereby patients 
have extra feelings and behaviors such as hallucinations and delusions. In the negative 
symptoms, such as asociality, apathy and cognitive problems, patients lack behaviors and 
feelings that usually are present (Kay et al., 1987) in healthy human beings. Even though 
the numbers of studies on schizophrenia are enormous the real understanding of the 
disease mechanisms is still lacking. 
 An important tool that reveal the disrupted systems of the schizophrenic 
CNS have been the various knockout mouse models available (Jones et al., 2011; Nestler 
and Hyman, 2010). Modeling of complex human cognition related sickness in rodents is 
challenging but certain behavioral features have been linked to the symptoms of human 
schizophrenia and these include prepulse inhibition, memory deficiency, hyperactivity and 
social problems (Gainetdinov et al., 2001; Lai et al., 2014; Papaleo et al., 2012; Powell et 
al., 2012). 
When the behavioral problems of the AMIGO deficient mice are surveyed 
together one notes that the disrupted behavioral domains are also found in well-established 
mouse models of schizophrenia (see table I). The listed domains in such models are 
hyperactivity, PPI deficit, social deficit and memory deficit. An important finding is that 
the Amigo KO mice recapitulate all these human schizophrenia related behavioral 
disturbances. This result strongly suggests that the human AMIGO gene should be taken as 
a potential candidate gene for schizophrenia. We speculate that in the adult human CNS 
AMIGO is needed to fine tune the Kv2.1 voltage-gating properties and a loss of AMIGO 
could cause a situation where the neurons are excessively prone to firing action potentials, 
which lead to an overactive CNS. Support for neuronal hyperactivity in schizophrenic 
brains have come from many studies where the overactivation could be located in many 
distinct brain areas and functions (Del Pino et al., 2013; Huffaker et al., 2009; Suh et al., 
2013). The common feature is that even though the disrupted functions of the brain can 
vary they all are processed at brain level as disrupted neuronal synchrony that leads to 
schizophrenia like symptoms (Uhlhaas and Singer, 2010). The AMIGO-Kv2.1 
relationship was clearly seen in zebrafish for which AMIGO deficiency resulted in 
hyperactivity and defective sensorimotor functions. Those behavioral phenotypes seen in 
zebrafish were rescued by ectopic expression of Kv2.1. Interestingly, a recent study on 
mice deficient in Kv2.1 also show a similar hyperactive phenotype compared to that seen 
in the Amigo KO mice (Speca et al., 2014). We suggest that behavioral changes seen in the 
AMIGO deficient mice are due to misbehaving Kv2.1 channels and AMIGO´s role in the 
adult CNS is mediated through regulation of Kv2.1 channels.  
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Table 2. Behavioral problems reported in mouse models of schizophrenia and their existence in 
AMIGO KO mouse 
 
 
 
 
 
 
mouse models of schizophrenia 
hyper- 
activity 
PPI 
deficit 
social 
deficit 
memory 
deficit 
BACE1 KO (Savonenko et al., 2008)    
Calcineurin KO (Miyakawa et al., 2003)    
Del22q11mouse model (Paylor et al., 2001)      
Corticotropin releasing factor overexpression 
(Dirks et al., 2002)        
DBA/2 mouse (Stevens et al., 1998)        
DISC1 DN mouse (Hikida et al., 2007)   

  
Disheveled 1 KO (Lijam et al., 1997)       
DAT KO (Giros et al., 1996; Morice et al., 2007; Ralph 
et al., 2001)      
ErbB4 conditional KO (Del Pino et al., 2013)    
GABA A alpha3 receptor KO (Yee et al., 2005)       
GAP-43 KO (Metz and Schwab, 2004)       
GDI1 KO (D'Adamo et al., 2002)      
Grin1(D481N) mutant (Kew et al., 2000; Labrie et al., 
2008) 

   
Heterozygous Nurr1 KO (Rojas et al., 2007)      
Heterozygous Reeler mouse (Barr et al., 2008; 
Krueger et al., 2006)    


Homer 1a KO (Szumlinski et al., 2005)     
mGluR1 KO (Brody et al., 2003)        
mGluR5 KO (Gray et al., 2009)       
NCAM-180 KO (Wood et al., 1998)        
Neuregulin 1 hypomorph (Stefansson et al., 2002)     
Neurexophilin 3 KO (Beglopoulos et al., 2005)        
NMDA NR1 hypomorph (Fradley et al., 2005; Mohn et 
al., 1999)      
nPAS 1/3 KO (Erbel-Sieler et al., 2004)  
 

Proline Dehydrogenase KO (Gogos et al., 1999)        
SREB transgenic mouse (Matsumoto et al., 2008a)     
STOP KO (Begou et al., 2008; Fradley et al., 2005)     
D2 receptor overexpression (Kellendonk et al., 2006) 
 
   
Type III Nrg1 KO (Chen et al., 2008)      
AMIGO KO (publication V)    
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8 Concluding remarks 
The construction of the human brain with its complex neuronal circuits and 
electrochemical functions is a marvelous product of half billion years of evolution. This 
work provides novel information as to how one gene called AMIGO from the pool of ca. 
20 000 human genes participates in developing the functional neuronal circuitry of brain. 
The remarkable small number of genes that when expressed constitute such a complex 
organism like a human being, necessitate many genes having pleiotropic roles and this 
seems to be also true in the case of Amigo. 
 
The conclusions of this work comprise two major parts: 
 
A. Discovery of the AMIGO family and the role in the developing CNS 
 
1. AMIGO defines a novel cell adhesion molecule family together with AMIGO2 and 
AMIGO3. 
2. AMIGO functions as a homophilic cell adhesion molecule during CNS 
development, which guides/supports neurite outgrowth through fasciculation. 
3. AMIGO crystallization as a dimer and structural studies suggest that dimerization 
has been conserved throughout the evolution of the AMIGO family. 
 
B. Role of AMIGO in adult CNS 
 
1. AMIGO is an auxiliary unit of the voltage-gated potassium channel Kv2.1 that 
fine-tunes the electrophysiological properties of the channel in the adult brain.  
2. Mice lacking AMIGO show reduced expression of Kv2.1 protein associated with 
changes in voltage-gated potassium currents. 
3. Deficiency of AMIGO leads to schizophrenia-related behavioral disturbances, 
which suggest that AMIGO should be considered as a candidate gene for human 
schizophrenia. 
 
Future work is warranted to reveal possible binding partners for the AMIGO cytosolic 
tail, which will reveal the cytosolic signaling properties of AMIGO alone in neurite 
outgrowth and together with the Kv2.1 complex in regulation of neuronal excitability. 
The mechanism of how AMIGO shifts the voltage-gating properties of Kv2.1 is an 
intriguing question for future studies.  
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Suuret kiitokset rakkaille sukulaisilleni, jotka eivät olleet moksiskaan vaikka 
vastasin useamman vuoden, että väikkäri on valmis “parin vuoden päästä”. Kiitokset velipojille 
Mikalla ja Jaakolle kaikista hienoista hetkistä, niin tämän väitöskirjan aikana, kuin koko elämässä. 
Suuret kiitokset hyvälle ”äittäpuolelleni” Helille kaikesta tuesta ja ymmärryksestä. Osoitan 
kiitollisuuteni ”kummitustädilleni” Leenalle joka on hoitanut kummintehtävänsä niin hyvin kuin 
vain mahdollista. Kiitokset isotäti Ainille kaikista hienoista keskusteluista kahvikupposen äärellä. 
Lämmin kiitos ”varasiskolle ja varaveljelle” Kirsille ja Ramille niin lapsuuden leikeistä kuin 
hienoista hetkistä aikuisuudessa. Kiitokset myös sukulaisteni kumppaneille Maaritille, Titalle, 
Virpille ja Jannelle hienoista hetkistä yhdessä. 
Suurin kiitos kuuluu rakkaalle Liisulleni, jonka välittäminen ja tuki on ollut 
kullanarvoista, että tämä väitöskirja on saatu näiden kansien väliin. Arvostan kaikkia yhdessä 
viettämiämme hetkiä, vaikka joskus sen osoittaminen kiireen keskellä voi unohtua. Odotan innolla 
yhteistä tulevaisuuttamme tämän väitöskirjan jälkeen. 
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